Phosphatidylinositol 3-kinase inhibitor suppresses inducible nitric oxide synthase expression in bronchiole epithelial cells in asthmatic rats

Molecular and Cellular Biochemistry

Volumn 359, Issue 1-2, 2012, Pages 293-299

  Xia, Xiaodong ^a   Hu, Xiaoguang ^a   Xu, Hui ^a   Wu, Liqin ^a   Dai, Yuanrong ^a   Yang, Lei ^a   Xu, Zhengjie ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Airway inflammation; Asthma; Inducible nitric oxide synthase; Nitric oxide; Phosphatidylinositol 3 kinase

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 4; MESSENGER RNA; PLACEBO; WORTMANNIN;

AEROSOL; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BRONCHIOLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; IMMUNOHISTOCHEMISTRY; LUNG LAVAGE; LUNG PARENCHYMA; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SENSITIZATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANDROSTADIENES; ANIMALS; ASTHMA; BRONCHIOLES; ENZYME INHIBITORS; EPITHELIAL CELLS; INFLAMMATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN KINASE INHIBITORS; RATS; SIGNAL TRANSDUCTION;

ANIMALIA; RATTUS;

EID: 83555164967     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1023-y     Document Type: Article

References (35)

1. EM Coccia E Stellacci G Marziali, et al. 2000 IFN-gamma and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation Int Immunol 12 977 985 10882409 10.1093/intimm/12.7.977 1:CAS:528:DC%2BD3cXls12jt7g%3D (Pubitemid 30599352)
2. CM Prado EA Leick-Maldonado L Yano, et al. 2006 Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling Am J Respir Cell Mol Biol 35 457 465 16709960 10.1165/rcmb.2005-0391OC 1:CAS:528: DC%2BD28XhtFSjtL%2FI (Pubitemid 44479728)
3. SA Kharitonov D Yates RA Robbins, et al. 1994 Increased nitric oxide in exhaled air of asthmatic patients Lancet 343 133 135 7904001 10.1016/S0140-6736(94)90931-8 1:STN:280:DyaK2c7gsVektQ%3D%3D (Pubitemid 24028638)
4. W Steudel M Kirmse J Weimann, et al. 2000 Exhaled nitric oxide production by nitric oxide synthase-deficient mice Am J Respir Crit Care Med 162 1262 1267 11029328 1:STN:280:DC%2BD3M%2FisF2qsQ%3D%3D
5. PR Eynott N Paavolainen DA Groneberg, et al. 2003 Role of nitric oxide in chronic allergen-induced airway cell proliferation and inflammation J Pharmacol Exp Ther 304 22 29 12490571 10.1124/jpet.102.040295 1:CAS:528: DC%2BD3sXht1Sjsw%3D%3D (Pubitemid 36008908)
6. B Vanhaesebroeck K Ali A Bilancio, et al. 2005 Signalling by PI3K isoforms: insights from gene-targeted mice Trends Biochem Sci 30 194 204 15817396 10.1016/j.tibs.2005.02.008 1:CAS:528:DC%2BD2MXjtVyqsrw%3D (Pubitemid 40463309)
7. D Chantry A Vojtek A Kashishian, et al. 1997 p110delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes J Biol Chem 272 19236 19241 9235916 10.1074/jbc.272.31.19236 1:CAS:528:DyaK2sXltFSmsrc%3D (Pubitemid 27337713)
8. VP Krymskaya AJ Ammit RK Hoffman, et al. 2001 Activation of class IA PI3K stimulates DNA synthesis in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol 280 L1009 L1018 11290526 1:CAS:528:DC%2BD3MXjsVahtbc%3D
9. K Ito G Caramori IM Adcock 2007 Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease J Pharmacol Exp Ther 321 1 8 17021257 10.1124/jpet.106.111674 1:CAS:528: DC%2BD2sXktVSks70%3D (Pubitemid 46456952)
10. M Takeda W Ito M Tanabe, et al. 2010 The pathophysiological roles of PI3Ks and therapeutic potential of selective inhibitors in allergic inflammation Int Arch Allergy Immunol 152 90 95 20523070 10.1159/000312132 1:CAS:528:DC%2BC3cXntFSmtr0%3D
11. M Thomas C Owen 2008 Inhibition of PI-3 kinase for treating respiratory disease: good idea or bad idea? Curr Opin Pharmacol 8 267 274 18394961 10.1016/j.coph.2008.02.004 1:CAS:528:DC%2BD1cXmvVylsrs%3D
12. W Duan AM Aguinaldo Datiles BP Leung, et al. 2005 An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model Int Immunopharmacol 5 495 502 15683846 10.1016/j.intimp.2004.10.015 1:CAS:528:DC%2BD2MXosFygsg%3D%3D (Pubitemid 40430757)
13. CI Ezeamuzie J Sukumaran E Philips 2001 Effect of wortmannin on human eosinophil responses in vitro and on bronchial inflammation and airway hyperresponsiveness in rats in vivo Am J Respir Crit Care Med 164 1633 1639 11719302 1:STN:280:DC%2BD3Mnnt12huw%3D%3D (Pubitemid 33124151)
14. KS Lee HK Lee JS Hayflick, et al. 2006 Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model FASEB J 20 455 465 16507763 10.1096/fj.05-5045com 1:CAS:528:DC%2BD28Xis1WksLg%3D (Pubitemid 44933322)
15. Y Xiong G Karupiah SP Hogan, et al. 1999 Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2 J Immunol 162 445 452 9886418 1:CAS:528:DyaK1MXjtlSjsg%3D%3D (Pubitemid 29018952)
16. GT De Sanctis JA MacLean K Hamada, et al. 1999 Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma J Exp Med 189 1621 1630 10330441 10.1084/jem.189.10.1621 (Pubitemid 29240887)
17. LE Donnelly PJ Barnes 2002 Expression and regulation of inducible nitric oxide synthase from human primary airway epithelial cells Am J Respir Cell Mol Biol 26 144 151 11751214 1:CAS:528:DC%2BD38XmslKqtg%3D%3D (Pubitemid 34029831)
18. J Jiang N Malavia V Suresh, et al. 2009 Nitric oxide gas phase release in human small airway epithelial cells Respir Res 10 24 31 10.1186/1465-9921-10-3
19. K Takemoto K Ogino M Shibamori, et al. 2007 Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma Am J Physiol Lung Cell Mol Physiol 293 L1419 L1426 17890324 10.1152/ajplung.00418.2006 1:CAS:528:DC%2BD2sXhsVGlsL%2FO (Pubitemid 350255024)
20. M Schedel LA Pinto B Schaub, et al. 2008 IRF-1 gene variations influence IgE regulation and atopy Am J Respir Crit Care Med 177 613 621 18079498 10.1164/rccm.200703-373OC 1:CAS:528:DC%2BD1cXksFSktr0%3D (Pubitemid 351442168)
21. R Dai RA Phillips E Karpuzoglu, et al. 2009 Estrogen regulates transcription factors STAT-1 and NF-kappaB to promote inducible nitric oxide synthase and inflammatory responses J Immunol 183 6998 7005 19890039 10.4049/jimmunol.0901737 1:CAS:528:DC%2BD1MXhsVehsb7I
22. JM Bratt LM Franzi AL Linderholm, et al. 2009 Arginase enzymes in isolated airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin Toxicol Appl Pharmacol 234 273 280 19027033 10.1016/j.taap.2008.10. 007 1:CAS:528:DC%2BD1MXhtlClsb4%3D
23. LS Feder D Stelts RW Chapman, et al. 1997 Role of nitric oxide on eosinophilic lung inflammation in allergic mice Am J Respir Cell Mol Biol 17 436 442 9376118 1:CAS:528:DyaK2sXmvVKjur0%3D (Pubitemid 127500976)
24. YJ Kang YS Lee GW Lee, et al. 1999 Inhibition of activation of nuclear factor kappaB is responsible for inhibition of inducible nitric oxide synthase expression by higenamine, an active component of aconite root J Pharmacol Exp Ther 291 314 320 10490919 1:CAS:528:DyaK1MXmtlaksbs%3D (Pubitemid 29451605)
25. KL Khanduja G Kaushik S Khanduja, et al. 2011 Corticosteroids affect nitric oxide generation, total free radicals production, and nitric oxide synthase activity in monocytes of asthmatic patients Mol Cell Biochem 346 31 37 20842520 10.1007/s11010-010-0588-1 1:CAS:528:DC%2BC3cXhsFSmurvM
26. YG Kwak CH Song HK Yi, et al. 2003 Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma J Clin Invest 111 1083 1092 12671058 1:CAS:528:DC%2BD3sXislOgtrY%3D (Pubitemid 36397485)
27. S Myou AR Leff S Myo, et al. 2003 Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT J Exp Med 198 1573 1582 14623911 10.1084/jem.20030298 1:CAS:528:DC%2BD3sXptFOgsLo%3D (Pubitemid 37467171)
28. B Tigani JP Hannon L Mazzoni, et al. 2000 Effects of wortmannin on bronchoconstrictor responses to adenosine in actively sensitised Brown Norway rats Eur J Pharmacol 406 469 476 11040355 10.1016/S0014-2999(00)00705-6 1:CAS:528:DC%2BD3cXntlKju78%3D
29. JA Marwick KF Chung IM Adcock 2010 Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease Ther Adv Respir Dis 4 19 34 20051446 10.1177/1753465809352792
30. Y Hattori S Hattori K Kasai 2003 Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation Eur J Pharmacol 481 153 158 14642780 10.1016/j.ejphar.2003.09.034 1:CAS:528:DC%2BD3sXpt1Cjtbg%3D (Pubitemid 37464964)
31. V Pinho DG Souza MM Barsante, et al. 2005 Phosphoinositide-3 kinases critically regulate the recruitment and survival of eosinophils in vivo: importance for the resolution of allergic inflammation J Leukoc Biol 77 800 810 15860799 10.1189/jlb.0704386 1:CAS:528:DC%2BD2MXktFenur8%3D (Pubitemid 40628760)
32. SJ Kao HC Lei CT Kuo, et al. 2005 Lipoteichoic acid induces nuclear factor-kappaB activation and nitric oxide synthase expression via phosphatidylinositol 3-kinase, Akt, and p38 MAPK in RAW 264.7 macrophages Immunology 115 366 374 15946254 10.1111/j.1365-2567.2005.02160.x 1:CAS:528:DC%2BD2MXlvFCms7o%3D (Pubitemid 40896035)
33. K Sakai H Suzuki H Oda, et al. 2006 Phosphoinositide 3-kinase in nitric oxide synthesis in macrophage: critical dimerization of inducible nitric-oxide synthase J Biol Chem 281 17736 17742 16636057 10.1074/jbc.M601896200 1:CAS:528:DC%2BD28XmtFyksb0%3D (Pubitemid 44035572)
34. E Kuroda F Antignano VW Ho, et al. 2011 SHIP represses Th2 skewing by inhibiting IL-4 production from basophils J Immunol 186 323 332 21131429 10.4049/jimmunol.1002778 1:CAS:528:DC%2BC3cXhs1ajtLrI
35. AS Kristof J Fielhaber A Triantafillopoulos, et al. 2006 Phosphatidylinositol 3-kinase-dependent suppression of the human inducible nitric-oxide synthase promoter is mediated by FKHRL1 J Biol Chem 281 23958 23968 16687394 10.1074/jbc.M513918200 1:CAS:528:DC%2BD28XotVClsrg%3D (Pubitemid 44274170)